National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 4011 [2023-01193]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 14 / Monday, January 23, 2023 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Stimulants and HIV: Addressing
Contemporary and Recurring Epidemics.
Date: March 1, 2023.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Marisa Srivareerat, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Office of Extramural Policy, National
Institute on Drug Abuse, NIH, 301 North
Stonestreet Avenue, MSC 6021, Bethesda,
MD 20892, (301) 435–1258,
marisa.srivareerat@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Reaching Equity at the Intersection of HIV
and Substance Use.
Date: March 6, 2023.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Marisa Srivareerat, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Office of Extramural Policy, National
Institute on Drug Abuse, NIH, 301 North
Stonestreet Avenue, MSC 6021, Bethesda,
MD 20892, (301) 435–1258,
marisa.srivareerat@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIH
Blueprint for Neuroscience Research:
Computational Training in Neuroscience and
Behavior.
Date: March 14, 2023.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Soyoun Cho, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301
North Stonestreet Avenue, MSC 6021,
Bethesda, MD 20892, (301) 594–9460,
Soyoun.cho@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
VerDate Sep<11>2014
16:44 Jan 20, 2023
Jkt 259001
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: January 18, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–01191 Filed 1–20–23; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group; Microbiology and Infectious Diseases
B Research Study Section Microbiology and
Infectious Diseases B Subcommittee.
Date: March 1–3, 2023.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F58,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Mario Cerritelli, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
5601 Fishers Lane, Room 3F58, Rockville,
MD 20892, 240–669–5199, cerritem@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 18, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–01193 Filed 1–20–23; 8:45 am]
BILLING CODE 4140–01–P
Frm 00046
Fmt 4703
ADVISORY COUNCIL ON HISTORIC
PRESERVATION
Exemption From Historic Preservation
Review for General Services
Administration Routine Operations and
Maintenance
Advisory Council on Historic
Preservation.
ACTION: Approval of exemption.
AGENCY:
The Advisory Council on
Historic Preservation has approved an
exemption that relieves the General
Services Administration from historic
preservation review requirements under
the National Historic Preservation Act
for specified routine operations and
maintenance activities.
DATES: The exemption went into effect
on January 13, 2023.
FOR FURTHER INFORMATION CONTACT:
Laura Lavernia, (202) 517–0225,
llavernia@achp.gov.
SUPPLEMENTARY INFORMATION: Section
106 of the National Historic
Preservation Act (section 106) requires
federal agencies to take into account the
effects of projects, activities, or
programs they carry out, license, or
assist on historic properties
(undertakings) and afford the Advisory
Council on Historic Preservation
(ACHP) a reasonable opportunity to
comment with regard to such
undertakings. Historic properties are
those that are listed or have been
determined eligible for listing in the
National Register of Historic Places
(NRHP).
The National Historic Preservation
Act (NHPA) authorizes the ACHP to
promulgate regulations for exempting
undertakings ‘‘from any or all the
requirements of’’ the NHPA. The section
106 implementing regulations, 36 CFR
800, detail the process for the approval
of such exemptions.
In accordance with 36 CFR
800.14(c)(1), the ACHP may approve an
exemption for an undertaking if it finds
that: (i) the actions within the program
or category would otherwise qualify as
‘‘undertakings’’ as defined in 36 CFR
800.16; (ii) the potential for effects of
the undertakings within the program or
category upon historic properties are
foreseeable and likely to be minimal or
not adverse; and (iii) exemption of the
program or category is consistent with
the purposes of the NHPA.
SUMMARY:
BILLING CODE 4140–01–P
PO 00000
4011
Sfmt 4703
I. Background
General Services Administration (GSA)
Use of 36 CFR 800.14 for Regional
Routine Operations and Maintenance
In accordance with the regulations
and processes outlined in 36 CFR
E:\FR\FM\23JAN1.SGM
23JAN1
]]>Agencies
[Federal Register Volume 88, Number 14 (Monday, January 23, 2023)]
[Notices]
[Page 4011]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01193]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Microbiology, Infectious Diseases and AIDS
Initial Review Group; Microbiology and Infectious Diseases B
Research Study Section Microbiology and Infectious Diseases B
Subcommittee.
Date: March 1-3, 2023.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3F58,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Mario Cerritelli, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, 5601 Fishers Lane, Room 3F58, Rockville, MD 20892, 240-
669-5199, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: January 18, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-01193 Filed 1-20-23; 8:45 am]
BILLING CODE 4140-01-P
